New CDC HIV surveillance report demonstrates national response must be accelerated

Progress to Ending HIV in the US Remains Stalled

Washington, D.C. — Yesterday the CDC released HIV prevention surveillance data for 2024 showing that the annual number of new diagnoses remains at nearly 39,000; virally suppression increased slightly from 67% to 69%; and 22% of the those newly diagnosed already had AIDS, meaning they were diagnosed late; and the communities and populations disproportionately impacted by HIV remained constant. In response, Carl Schmid, executive director of the HIV+Hepatitis Policy Institute, released the following statement:

“This data demonstrates that we are not making significant progress in reducing HIV in the United States and efforts to end HIV, unfortunately, remain stalled. Without a jumpstart of resources and a renewed national commitment and leadership by public officials across the country, we are destined to continue to fall short in meeting our goals. While we have many of the tools to end HIV, including effective antiretroviral treatment and PrEP that prevents HIV, we need HIV programs and policies, along with sufficient funding, to ensure they are delivered to the people who need them. President Trump launched an ambitious program to end HIV in his first term, which included dedicated and targeted funding to ramp up HIV treatment and prevention.  If we are to make future progress, we need a national recommitment to those goals along with a rejection of over $2 billion in proposed cuts to domestic HIV prevention, treatment, research and housing programs.”

# # #

The HIV+Hepatitis Policy Institute is a national, non-profit organization whose mission is to promote quality and affordable healthcare for people living with or at risk of HIV, hepatitis, and other serious and chronic health conditions.